Press "Enter" to skip to content

Array Biopharma on the Rise after Colorectal Cancer Trial Success – The Stock Tribune

admin 0

Array Biopharma on the Rise after Colorectal Cancer Trial Success  The Stock Tribune

Array Biopharma Inc.’s (NASDAQ: ARRY) shares spiked 22.95 percent to close at $ 25.77 a share on Tuesday. The stock traded between $ 21.94 and $ 26.82 on …

“colorectal cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *